Advertisement
Screener

IBIO, INC. (IBIO) Graph

IBIO Revenue Flow

Filed revenue amounts for 2025-07-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue $0.00*; Revenue including tax (m); Cost of revenue (m); Research and development $8.56M*.
  • 2026-03-31: Revenue (m); Revenue including tax (m); Cost of revenue (m); Research and development $3.25M.
  • 2025-12-31: Revenue $0.00; Revenue including tax (m); Cost of revenue (m); Research and development $4.28M.
  • 2025-09-30: Revenue $100.00K; Revenue including tax (m); Cost of revenue (m); Research and development $3.55M.

Product or service

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

IBIO revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Collaborative Revenues$100.00KRevenue$100.00KOperating expenses$35.24MOperating income-$35.14MResearch & development$19.64MPre-tax income-$33.04MIncome tax$0.00Net income-$33.04M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueRevenue including taxCost of revenueResearch and developmentOperating expensesIncome taxNet income
2026-06-30$0.00*(m)(m)$8.56M*$11.38M*$0.00*-$10.40M*
2026-03-31(m)(m)(m)$3.25M$8.37M$0.00-$7.73M
2025-12-31$0.00(m)(m)$4.28M$9.45M$0.00-$8.99M
2025-09-30$100.00K(m)(m)$3.55M$6.05M$0.00-$5.72M
2025-03-31$0.00(m)(m)$1.91M$4.88M$0.00-$4.86M
2024-12-31$200.00K(m)(m)$1.88M$4.62M$0.00-$4.36M
2024-09-30$0.00(m)(m)$1.30M$4.11M$0.00-$3.99M
2024-03-31(m)(m)(m)$904.00K$3.63M$0.00-$3.17M
2023-12-31(m)(m)(m)$1.53M$4.50M$0.00-$8.21M
2023-09-30$50.00K(m)(m)$1.61M$5.15M$0.00-$5.75M
2023-03-31$0.00(m)(m)$2.64M$6.17M$0.00-$7.29M
2022-12-31$0.00(m)(m)$2.78M$10.57M$0.00-$33.55M
2022-09-30$0.00(m)(m)$2.55M$7.64M$0.00-$18.13M
2022-06-30(m)(m)$15.00K*(m)(m)(m)-$17.05M*
2022-03-31$1.80M(m)$48.00K$3.27M$8.59M$0.00-$12.39M
2021-12-31$0.00(m)$113.00K$1.86M$7.23M$0.00-$11.92M
2021-09-30$84.00K(m)$40.00K$1.13M$5.31M$0.00-$8.94M
2021-03-31$765.00K(m)$493.00K$2.16M$7.47M(m)-$7.66M
2020-12-31$705.00K(m)$211.00K$2.37M$8.04M(m)-$8.13M
2020-09-30$410.00K(m)$107.00K$1.86M$7.23M$0.00-$7.53M
2020-06-30(m)$0.00*(m)(m)(m)(m)(m)
2020-03-31$96.00K$0.00$86.00K$1.09M$4.07M(m)-$4.68M
2019-12-31$314.00K$0.00(m)$888.00K$3.47M$0.00-$3.76M
2019-09-30$108.00K(m)(m)$977.00K$3.96M$0.00-$4.46M
2019-03-31$527.00K$0.00(m)$1.45M$4.30M(m)-$4.22M
2018-12-31$651.00K$37.00K(m)$1.27M$4.67M$0.00-$4.47M
2018-09-30$45.00K(m)(m)$1.12M$4.00M$0.00-$4.40M
2018-03-31$78.00K(m)(m)$966.00K$3.57M(m)-$3.96M
2017-12-31$153.00K(m)(m)$993.00K$3.58M(m)-$3.90M
2017-09-30$122.00K(m)(m)$985.00K$3.48M(m)-$3.83M
2017-03-31$37.00K(m)(m)$1.14M$3.97M(m)-$3.91M
2016-12-31$75.00K(m)(m)$1.05M$3.40M(m)-$3.23M
2016-09-30$135.00K(m)(m)$820.00K$3.29M(m)-$3.06M
2016-03-31$379.00K(m)(m)$1.05M$3.45M(m)-$3.04M
2015-12-31$134.00K(m)(m)$704.00K$2.39M(m)-$2.25M
2015-09-30$160.00K(m)(m)$551.00K$1.97M(m)-$1.80M
2015-03-31$349.00K(m)(m)$815.00K$2.04M(m)-$1.68M
2014-12-31$367.00K(m)(m)$731.00K$2.03M(m)-$1.65M
2014-09-30$819.00K(m)(m)$1.19M$2.23M(m)-$1.41M
2014-03-31$0.00(m)(m)$343.00K$1.29M(m)-$1.28M
2013-12-31$0.00(m)(m)$585.00K$1.64M(m)-$1.63M
2013-09-30$0.00(m)(m)$552.00K-$240.00K$0.00$379.00K
2013-03-31$0.00(m)(m)$631.00K$1.86M$0.00-$1.76M
2012-12-31$0.00(m)(m)$656.00K$1.70M(m)-$1.07M
2012-09-30$390.00K(m)(m)$1.18M$2.20M$0.00-$2.05M
2012-03-31$371.75K(m)(m)$1.31M$2.55M$0.00-$3.10M
2011-12-31$233.83K(m)(m)$1.16M$2.91M(m)-$1.60M
2011-09-30$320.35K(m)(m)$1.46M$2.65M(m)$383.14K
2011-03-31$176.00K(m)(m)$1.14M$3.06M(m)-$3.03M
2010-12-31(m)(m)(m)$619.54K$1.87M(m)-$4.71M
2010-09-30(m)(m)(m)$157.54K$1.37M(m)-$2.82M

Revenue and expense 6 month

Period endRevenueRevenue including taxCost of revenueResearch and developmentOperating expensesIncome taxNet income
2025-12-31$100.00K(m)(m)$7.83M$15.50M$0.00-$14.71M
2024-12-31$200.00K(m)(m)$3.18M$8.72M$0.00-$8.35M
2023-12-31$50.00K(m)(m)$3.14M$9.65M$0.00-$13.96M
2022-12-31(m)(m)(m)$5.33M$18.21M(m)(m)
2021-12-31$84.00K(m)$153.00K$2.99M$12.54M$0.00-$20.86M
2020-12-31$1.11M(m)$318.00K$4.24M$15.27M$0.00-$15.66M
2019-12-31$422.00K$0.00(m)$1.86M$7.43M$0.00-$8.22M
2018-12-31$696.00K$37.00K(m)$2.40M$8.66M$0.00-$8.87M
2017-12-31$275.00K(m)(m)$1.98M$7.06M(m)-$7.72M
2016-12-31$210.00K(m)(m)$1.87M$6.69M(m)-$6.29M
2015-12-31$294.00K(m)(m)$1.25M$4.36M(m)-$4.05M
2014-12-31$1.19M(m)(m)$1.92M$4.27M(m)-$3.06M
2013-12-31$0.00(m)(m)$1.14M$1.40M$0.00-$1.25M
2012-12-31$390.00K(m)(m)$1.83M$3.90M$0.00-$3.12M
2011-12-31$554.18K(m)(m)$2.62M$5.55M(m)-$1.21M
2010-12-31(m)(m)(m)$777.08K$3.24M(m)-$7.53M

Revenue and expense 9 month

Period endRevenueRevenue including taxCost of revenueResearch and developmentOperating expensesIncome taxNet income
2026-03-31$100.00K(m)(m)$11.08M$23.86M$0.00-$22.44M
2025-03-31$200.00K(m)(m)$5.09M$13.60M$0.00-$13.21M
2024-03-31$50.00K(m)(m)$4.04M$13.28M$0.00-$17.13M
2023-03-31(m)(m)(m)$7.97M$24.38M$0.00(m)
2022-03-31$1.88M(m)$201.00K$6.26M$21.13M$0.00-$33.25M
2021-03-31$1.88M(m)$1.27M$6.89M$22.28M$0.00-$23.32M
2020-03-31$518.00K$0.00$404.00K$2.99M$11.19M$0.00-$12.90M
2019-03-31$1.22M$37.00K(m)$3.85M$12.96M(m)-$13.09M
2018-03-31$353.00K(m)(m)$2.94M$10.63M(m)-$11.69M
2017-03-31$247.00K(m)(m)$3.00M$10.66M(m)-$10.20M
2016-03-31$673.00K(m)(m)$2.30M$7.81M(m)-$7.09M
2015-03-31$1.53M(m)(m)$2.73M$6.30M(m)-$4.74M
2014-03-31$0.00(m)(m)$1.48M$2.69M$0.00-$2.52M
2013-03-31$390.00K(m)(m)$2.46M$5.75M$0.00-$4.88M
2012-03-31$925.93K(m)(m)$3.93M$8.11M$0.00-$4.31M
2011-03-31$176.00K(m)(m)$1.91M$6.30M(m)-$10.56M

Revenue and expense 12 month

Period endRevenueRevenue including taxCost of revenueResearch and developmentOperating expensesIncome taxNet income
2026-06-30$100.00K(m)(m)$19.64M$35.24M$0.00-$32.84M
2025-06-30$400.00K(m)(m)$8.31M$19.00M$0.00-$18.38M
2024-06-30$225.00K(m)(m)$5.18M$16.86M$0.00-$24.91M
2023-06-30$0.00(m)(m)$10.33M$29.34M$0.00-$65.01M
2022-06-30$1.88M(m)$216.00K$9.83M$31.58M$0.00-$50.30M
2021-06-30$2.37M(m)$1.46M$9.99M$32.02M$0.00-$23.21M
2020-06-30$1.64M$0.00$703.00K$3.57M$14.94M$0.00-$16.44M
2019-06-30$2.02M$37.00K(m)$5.47M$17.81M$0.00-$17.59M
2018-06-30$444.00K$44.00K(m)$3.99M$14.67M$0.00-$16.11M
2017-06-30$394.00K(m)(m)$4.12M$14.67M$0.00-$14.53M
2016-06-30$948.00K(m)(m)$3.16M$10.84M$0.00-$9.76M
2015-06-30$1.85M(m)(m)$3.50M$8.52M$0.00-$6.63M
2014-06-30$205.00K(m)(m)$1.90M$4.04M$0.00-$3.67M
2013-06-30$1.01M(m)(m)$3.43M$7.67M$0.00-$6.20M
2012-06-30$1.28M(m)(m)$4.98M$10.60M$0.00-$5.68M
2011-06-30$520.08K(m)(m)$3.08M$10.17M(m)-$12.14M

Similar stocks

Stock NameCountryMarket CapPE Ratio
MAIA Biotechnology, Inc. (MAIA)United States$0.077B-2.30
Valion Bio, Inc. (VBIO)United States$0.077B
Adicet Bio, Inc. (ACET)United States$0.078B-0.81
Verrica Pharmaceuticals Inc. (VRCA)United States$0.076B-3.39
Lifevantage Corp (LFVN)United States$0.078B15.40
OS Therapies Inc (OSTX)United States$0.076B-2.17
Gain Therapeutics, Inc. (GANX)United States$0.080B-4.40
Aldeyra Therapeutics, Inc. (ALDX)United States$0.074B-5.57
Cingulate Inc. (CING)United States$0.073B-2.64
Spero Therapeutics, Inc. (SPRO)United States$0.073B17.41